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DETERMINING TREATMENT OUTCOMES OF TRAUMATIC BRAIN INJURY 
PHILIPPE MOLEUS 
ABSTRACT 
 Traumatic brain injury (TBI) is a major health problem affecting the adult and 
pediatric population. Scientists and clinicians are working diligently to discover possible 
therapeutics for the treatment of TBI. Two possible treatments to deal with TBI include 
sleep and the administration of progesterone. Yet, there are conflicting results from 
studies regarding the efficacy of either treatment. Sleep appears to reduce 
neuroinflammation and reduce axonal damage in the brain following TBI. Sleep 
deprivation, however, may have neuroprotective effects after TBI. Progesterone has also 
been shown to have neuroprotective effects following TBI. But, there are no sufficient 
data from animal studies to determine if progesterone is an effective therapeutic. More 
research studies will have to be conducted to further understand the role of sleep and 
progesterone in alleviating TBI. 
  
  vii 
 TABLE OF CONTENTS  
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
DEDICATION ................................................................................................................... iv 
ACKNOWLEDGMENTS .................................................................................................. v 
ABSTRACT ....................................................................................................................... vi 
LIST OF TABLES ............................................................................................................. ix 
LIST OF FIGURES ............................................................................................................ x 
LIST OF ABBREVIATIONS ........................................................................................... xii 
INTRODUCTION .............................................................................................................. 1 
Inflicting TBI in Rodent Models .............................................................................. 1 
         Therapeutic Effects of Sleep……………….……......…………………………………. 3 
   
        Therapeutic Effects of Progesterone………………………………………………6 
 
SPECIFIC AIMS…...........................................................................................................11 
 
NEUROPATHOLOGICAL FINDINGS OF TBI…………………………………...…..12 
         Inflammatory Response……………………………………………………….….12 
       
       Axonal Degeneration……………………………………………............................14 
 
SLEEP CYCLE IN MAMMALS ..................................................................................... 16 
  viii 
RELATIONSHIP BETWEEN SLEEP AND TBI ............................................................ 18 
         Sleep Disorders after TBI................................................................................................18 
 
         Cellular Events Associated with Sleep Disruption…........…………………………19 
 
         Benefit of Sleep after TBI…………………………. ….……………………………….20 
 
         Neuroprotective Role of Sleep Deprivation………………………….……………...23 
 
         Detrimental Effect of Sleep Deprivation……………………………………….……28 
 
PROGESTERONE TREATMENT .................................................................................. 28 
         Inflammation .......................................................................................................... 29 
          Cerebral Edema......................................................................................................36 
 
CONCLUSION…………………………………………………………...…………………….43 
 
REFERENCES ................................................................................................................. 44 
CURRICULUM VITAE ................................................................................................... 47 
 
  
  ix 
LIST OF TABLES 
 
 
Table Title Page 
1    Features of wakefulness, NREM sleep, and REM sleep 17 
   
   
   
   
   
 
 
  
  x 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1         Loss of consciousness (LOC) in seconds (s) in mice 
models following rmTBI or sham-injury 
3 
2 Sleep increases the clearance of Aβ in mice models 5 
3 Wire grip test performance improves in progesterone-
treated male mice following TBI 
9 
4 Macrophages removing dead cells following TBI 13 
5 The ‘dying back’ hypothesis and focal lesion  
 
hypothesis of axon degeneration 
15 
6 
7 
 
8 
9 
10 
 
11 
12 
 
The sleep cycle 
Effect of sleep deprivation and sleep rebound on CB1R 
expression 
The Rotor-Rod test 
The inclined plane task 
Histology suggesting delayed neuronal death at 7 days 
post MCAO 
Iba-1 immunohistochemistry to access microgliosis 
GFAP immunohistochemistry to access astrogliosis 
16 
22 
 
25 
26 
27 
 
31 
32 
 
  xi 
13 
 
 
14 
15  
 
16 
17 
 
 
1.  
The effect of ACI and progesterone treatment in 
ipsilateral hemispheres on TNF-α, IL-1β, BDNF, 
and G-CSF gene expression 
Edema formation in male and female rats 
Edema formation in male and female rats with treatment 
delay 
Serum progesterone levels 
Edema levels 48 hours post-injury 
 
35 
 
 
38 
39 
 
41 
42 
 
 
  
  xii 
LIST OF ABBREVIATIONS 
Aβ……………………………………………………………………………Amyloid Beta 
 
APP……………………………………………………………Amyloid Precursor Protein 
 
ACI…………………………………...……………………………Aseptic Cerebral Injury 
 
BBB……………………………………………………………………Blood Brain Barrier 
 
BDNF……………………….………………………. Brain-Derived Neurotrophic Factor 
 
CB1R……………………………….……………………………. Cannabinoid Receptor 1 
 
CCI…………………………………………………………… Controlled Cortical Impact 
CNO…………………………………………………………………...Clozapine-N-Oxide 
 
CNS……………………………………………………………… Central Nervous System 
 
CTX…………………………………………………………….……. Peri-Injury Cortex 
DAI…………………………………………………………………Diffuse Axonal Injury 
 
DREADDs………………Designer Receptors Exclusively Activated by Designer Drugs 
 
ECoG………………………………………………………………...Electrocorticography 
 
EEG………………………………………………………………. Electroencephalogram 
 
EMG………………………………………………………….………… Electromyogram 
 
FJB…………………………………………………………….…………… Fluoro-Jade B 
 
FPI……………………………………………….......................... Fluid Percussion Injury 
GAD…………………………………………………………... Gracile Axonal Dystrophy 
GFAP………………………………………………………. Glial Fibrillary Acid Protein 
G-CSF…………………………………………. Granulocyte – Colony Stimulating Factor 
hM……………………………………………………………….……. Human Muscarinic 
 
  xiii 
IC……………………………………………………………….……………. Infarct Core 
 
IL-1…………………………………………………………………………. Interleukin-1 
 
IL-1β………………………………………………………………………. Interleukin-1β 
 
LFP……………………………………………………………. Lateral Fluid Percussion 
 
LOC………………………………………………………………. Loss of Consciousness 
mRNA…………………….……………………………………………. Messenger RNA 
MWM………………………………………………………………… Morris Water Maze 
NREM………………………………………………………. Non-Rapid Eye Movement 
OPCs……………………………………....……………Oligodendrocyte Precursor Cells 
ORX……………………………………………………………………….……… Orexin 
ORX-A………………………………………………………………………… Orexin -A 
Ovex…………………………………………………...………… Ovariectomized Female 
PI……………………………………………………….……………………. Peri- Infarct 
REM…………………………………………………………....... Rapid Eye Movement 
ROS…………………………………………………………… Reactive Oxygen Species 
REMSD………………………………......………. Rapid Eye Movement Sleep Disorder 
RTN…………………………………………………………. Reticular Thalamic Nucleus 
rmTBI…………………………………………… Repetitive Mild Traumatic Brain Injury 
SDis…………………………………………………………………… Sleep Disturbances 
SDpv12h…….………………Sleep Disruption Including Sleep Deprivation for 12 Hours 
S.E.M………………………………………………………… Standard Error of the Mean 
SWS………………………………………………………………...........Slow Wave Sleep 
  xiv 
TBI………………………………………………………………...Traumatic Brain Injury 
TNFα……………………………………………………………. Tumor Necrosis Factor α 
TSD……………………………………………………….…………. Total Sleep Disorder 
WDIA…………………………………………………. Weight Drop Impact Acceleration 
 
 
 
 
 1 
INTRODUCTION 
 
Traumatic Brain Injury (TBI), usually the result of violence, vehicle accidents, or 
falls, is a major public health problem and affects 12% of the general population 
worldwide1. TBI, which results in the acceleration and deceleration of the head following 
an external impact, causes 120 million people worldwide to suffer from chronic post-
traumatic symptoms2. Some of the complaints following TBI and mild traumatic brain 
injury (mTBI) include vigilance and sleep deprivation3. With the prevalence and 
debilitating effects of TBI, scientists and clinicians are eager to discover effective 
therapeutics for the treatment of TBI. 
The incidence of repetitive mild traumatic brain injury (rmTBI) has also been 
increasing in young, nonprofessional athletes. About 25% of nonprofessional athletes in 
various sports have suffered multiple concussions4. In a clinical setting, rmTBI has been 
associated with neuropathological outcomes, such as memory disturbances, 
parkinsonism, and behavioral abnormalities4. Thus, in order to have an understanding of 
rmTBI, as well as TBI, researchers often use animal models (rodent models) to 
understand the behavioral and histopathological outcomes following TBI. 
 
Inflicting TBI in Rodent Models 
Scientists utilize several techniques to inflict TBI in rodent models. These 
techniques include: fluid percussion injury (FPI), controlled cortical impact (CCI), 
weight-drop impact acceleration (WDIA), and blast injury models. In the FPI model, a 
pendulum strikes a fluid reservoir to create a wave of pressure5. This wave of pressure 
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enters through an opening in the skull of the rodent onto the dural surface, which results 
in the limited movement and deformation of the brain5. The CCI model involves the use 
of a tool that has a solid rod which hits an exposed area of the rodent brain5. As a result 
of an injury from CCI, there is a deformation in the brain at the site injury, and 
deterioration in the cortical, thalamic, and hippocampal brain regions5. In the WDIA 
model, a free falling weight strikes a metal disk cemented onto a rodent’s skull5. The size 
of the weight and the distance the weight falls may vary in experiments. The WDIA 
causes the rodent brain to accelerate within its skull, which leads to widespread brain 
injury, yet does not fracture the skull5. The purpose of the blast injury model is to mimic 
the explosive blast forces experienced in military combat. A shock tube and compression 
forces replicate non-impact blast injuries5. 
Mannix et al., have utilized the WDIA model to assess behavioral tasks following 
rmTBI. Male mice between the ages of two to three months old were subjected to a 
weight drop model of rmTBI. The mice were first separated into two groups – the injured 
group (n = 32) and the sham-injured group (n=21)4. Both groups of mice were treated 
with 3% isoflurane in a 70:30 mixture of oxygen4. The rodents in the sham-injured group 
only received anesthesia. But, the rodents in the injured group received anesthesia and 
had a 54-gram metal bolt impact the top of the skull4. The rodents in the injured group 
had seven concussive injuries over the course of nine days. 
Following the procedural steps, the mice in both groups recovered consciousness. 
Figure 1 illustrates the difference in LOC between injured mice and sham-injured mice. 
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Figure 1. Loss of consciousness (LOC) in seconds (s) in mice models following 
rmTBI or sham-injury4. 
Injured mice had higher LOC than sham-injured mice on Days 1 and 2 of injury (*p < 
0.05 for both days). Following Day 2, there is no difference in LOC between both groups 
(p > 0.1). 53 mice were observed (32 injured mice and 21 sham-injured mice). 
 
 
The LOC – the time from removal of anesthesia to spontaneous righting reflex—of the 
rodents was then measured.4 The LOC represented the effects of the anesthesia and the 
rmTBI.4 
 
Therapeutic Effects of Sleep  
Sleep is identified as a possible therapeutic for TBI. Sleep has been associated 
with brain plasticity, learning and memory consolidation3. As a result, the lack of sleep 
following a TBI may prolong the symptoms related to the injury. The stage of sleep 
known as slow-wave sleep (SWS), or deep sleep, appears to be an important factor in 
improving neurological conditions following a TBI1. Modulating sleep in rat models to 
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increase time spent in the slow-wave sleep cycle has led to a decrease in diffuse axonal 
injury (DAI) and memory impairment – two consequences of TBI1. 
Sleep following a TBI has been shown to increase clearance of neurotoxic waste 
such as Amyloid Beta (Aβ), a protein associated with neurodegenerative diseases6. This 
finding suggests that sleep may be associated with metabolic homeostasis in the mouse 
model. Mice who received less sleep had less clearance of Aβ, which suggests that Aβ is 
produced during periods of wakefulness6. Slow wave activity, as measured by 
electrocorticography (ECoG), is higher in mice that sleep more than mice that sleep less. 
Figure 2 elucidates the effect of sleep on the clearance of Aβ. 
Mice suffering from mTBI appear to have sleep-wave disturbances3. That is, mice 
suffering from mTBI have shorter periods of wakefulness as well as slow ECoG wave 
activity during periods of wakefulness3. Additionally, it has been demonstrated that the 
mice had an increased inflammatory response, as evidenced by release of Interleukin-1 
(IL-1) and Necrosis Factor Alpha (TNFα), in the hippocampus and the cortex of the 
brain3. A consequence of inflammation post-TBI is that it may affect neurons important 
for the sleep-wake cycle. Therefore, understanding the role of the inflammatory response 
following mTBI may provide insight into how brain injury affects the sleep-wake cycle. 
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Figure 2. Sleep increases the clearance of Aβ in mice models6.     
A. Mice that were awake (orange triangles), sleeping (green diamonds), and anesthetized 
(red squares, ketamine/xylazine) received injections of 125I-Aβ1-40 in the frontal cortex. 
The panel represents the time-disappearance curves of 125I-Aβ1-40. B. Rate constants 
derived from the clearance curves. C. Mice that were awake (orange triangles), sleeping 
(green diamonds), and anesthetized (red squares, ketamine/xylazine) received injections 
of 14C-inulin in the frontal cortex. The panel represents the time-disappearance curves of 
14C-inulin. D. Rate constants derived from the clearance curves. 77 mice were included in 
the analysis (25 awake, 29 asleep, and 23 anesthetized).            
                         
 
Several animal models have been used to demonstrate the mechanism of TBI 
observed in humans. The Marmarou Impact Acceleration model represents an effective 
mouse model of frontal TBI2. The model causes a closed head injury in the front of the 
head, which is a common type of head injury that humans experience during a sporting 
event or motor vehicle collision7. The model results in: cognitive deficits three weeks 
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after the TBI, DAI, and an accumulation of amyloid precursor protein (APP) in the axons 
of hippocampal and cortical neurons. Consequently, the Marmarou Impact Acceleration 
model may be an effective technique to induce TBI in rodent models.     
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are 
useful tools in understanding the neuronal circuitry associated with behavior and may be 
used to delineate the effects of TBI on the brain7. One common type of DREADDs 
involves the inert ligand Clozapine-N-oxide (CNO), which binds to the human 
muscarinic (hM) receptor7. The advantage of this type of DREADDs is that the ligand 
can be injected intracranially or injected intraperitoneally and travel across the blood 
brain barrier (BBB)7.  Therefore, DREADDs may determine the location of active 
neurons in the brain following a TBI. 
 
Therapeutic Effects of Progesterone 
The therapeutic effects of the steroid hormone progesterone following TBI have 
been studied in adults, and, to a limited extent, in children. Several studies have indicated 
the neuroprotective effects of progesterone since female mice, when compared to male 
mice, had improved functional outcomes following TBI. Scientists, in particularly, have 
been interested in learning about effective treatments for TBI in the pediatric population 
since children are highly likely to suffer from this type of injury8. Mannix et al., 
conducted a research study to determine if progesterone had neuroprotective effects in 
adolescent mice. 
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Mannix et al., hypothesized that progesterone would improve functional and 
neuropathological outcomes in adolescent mice after the mice underwent CCI. The study 
included twenty-nine male and twenty-nine female adolescent (4 weeks old) C57B1/6 J 
mice8. The mice were randomly separated into two groups: 1) progesterone in 
cyclodextrin vehicle (8 mg/kg, intraperitoneally) and 2) vehicle alone (0.215 mmol 
cyclodextrin, intraperitoneally)8. About 32 mice (16 males and 16 females) were in the 
progesterone in cyclodextrin vehicle group, and about 26 mice (13 males and 13 females) 
were in the vehicle alone group8. The total volume injected in to the mice was 12.5 μL. 
Following the CCI procedure, mice were injected at two minutes post-injury, 6 hours 
post-injury, and daily every day after injury for four days (a total of 6 doses)8. 
Prior to beginning the sham procedure or the CCI procedure, mice were 
anesthetized using 3% isoflurane in a 70:30 mixture of nitrogen/oxygen8. Mice 
undergoing the CCI procedure had a 5-mm craniotomy over the left parietotemporal 
cortex with the removal of the bone flap8. The CCI device – a pneumatic cylinder with a 
3-mm flat-tip impounder, velocity of 6 m/sec, and impact depth of 0.6 mm – delivered 
the injury8. Mice in the sham group only received a craniotomy. The mice were 
additionally randomized to CCI injury group or sham injury group. Thirty-four mice [17 
males and 17 females] were in the CCI injury group8. Within the CCI injury group, each 
sex cohort had 10 mice treated with progesterone and 7 mice treated with vehicle. 
Twenty-four mice [12 males and 12 females] were in the sham injury group8. Within the 
sham injury group, each sex cohort had 6 mice treated with progesterone and 6 mice 
treated with vehicle. 
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Mannix et al., intended to assess the gross vestibular function and spatial memory 
performance following the CCI procedure8. The gross vestibular function was assessed 
with the wire grip test about one to eight days following the injury. With the wire grip 
test, a mouse was placed on a wire (several inches above a flat surface) suspended 
between two small wooden pillars8. The spatial memory performance was assessed with 
the Morris water maze (MWM) about 4-5 weeks following the injury. With the MWM, 
mice were placed (from four different locations) in a white pool (83 cm in diameter, 60 
cm deep) filled with water at a depth of 29 cm8. The goal of the test was to find a 
platform located 1 cm below the surface of the water8. The mice had only two trials of 
MWM in a day. 
The study concluded that each sex responded differently to progesterone 
following CCI. In regards to the wire grip test, the male mice that underwent CCI had 
improved wire grip scores following progesterone treatment8. On the contrary, the female 
mice that underwent CCI had worse wire grip scores following progesterone treatment8. 
Figure 3 demonstrates the differences in wire grip testing between the male and female 
mice treated with progesterone. 
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Figure 3. Wire grip test performance improves in progesterone-treated male mice 
following CCI8.      
Top panel. Progesterone-treated male mice that underwent CCI, when compared to 
vehicle-treated male mice that underwent CCI, had better vestibular motor function up to 
8 days post-injury (p < 0.001). Bottom panel. Progesterone-treated female mice, when 
compared to vehicle-treated female mice, had a worse performance on wire grip testing. 
 
 
With regards to the MWM, for each mouse sex, there was not any significant difference 
between progesterone-treated and vehicle-treated CCI-injured mice8. In addition, for each 
mouse sex, there was not any significant difference in MWM performance between 
progesterone-treated and vehicle-treated sham-injured mice8. Lastly, in regards to lesion 
volumes in the brain, there were not any significant differences between progesterone-
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treated and vehicle-treated CCI-injured male mice nor progesterone-treated and vehicle-
treated CCI-injured female mice8. 
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SPECIFIC AIMS 
 
 
The purpose of this literature thesis is to analyze scientific articles and journals in 
order to determine whether sleep and progesterone in the rodent model can alleviate the 
symptoms of TBI. Studies have suggested that rodents who spent more time in the slow 
wave stage of the sleep cycle following a TBI performed better on memory tests 
compared to rodents who did not. Other studies demonstrated that the steroid hormone 
progesterone has neuroprotective effects for rodents after TBI. One goal of this thesis is 
to determine whether an increase in sleep, independent of the stage, of sleep alleviates 
symptoms associated with TBI including axonal damage and memory deficits. Another 
goal to determine if increased sleep, following a TBI, may reduce chronic post-traumatic 
symptoms.  Lastly, the thesis intends to determine if progesterone can be a possible 
therapeutic following TBI.
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NEUROPATHOLOGICAL FINDINGS OF TBI 
 
Inflammatory Response 
 
 A significant biological response following trauma is neuroinflammation9.  
For instance, the immune cells microglia respond to inflammation within the central 
nervous system following TBI, and are associated with white matter degeneration9. But, 
several clinical trials have shown that anti-inflammatory drugs do not have a major 
therapeutic effect in humans following TBI9. Thus, some scientists believe that 
neuroinflammation may be beneficial for subjects following TBI9. Russo and McGavern 
analyzed the possible benefit of CNS following TBI. 
 Drugs with anti-inflammatory responses, such as corticosteroids, have produced 
variable results in different TBI animal models9. For instance, in one clinical trial, 
subjects suffering from TBI were treated with progesterone within four hours of the 
injury9. Six months following the injury, there was not a significant difference between 
the progesterone and placebo control group when analyzing mortality9. The findings 
suggest that anti-inflammatory drugs may possibly have adverse effects on patients 
suffering from TBI9. 
 Russo and McGavern postulate that some inflammation may be necessary for 
healing the CNS and clearing tissue damage within this system9. Immune cells within the 
CNS have the role of removing dead cells, supporting the BBB system, and initiating 
wound healing9. Figure 4 presents an example of the benefit of a macrophage with the 
CNS9. 
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Figure 4. Macrophages removing dead cells following TBI9.      
A and B. Meningeal macrophages are present in the meninges two days following injury, 
and act as scavengers of dead cells. Within the meningeal space, (A) one macrophage, 
which already engulfed a dead cell, is about to phagocytose another dead cell and (B) a 
macrophage scavenging a dead cell four days after injury. Macrophages are represented 
by the green color and dead cells are represented by the red color. 
 
Russo and McGavern speculate that neuroinflammatory responses during the acute phase  
of TBI may benefit subjects9. Thus, using anti-inflammatory drugs to treat TBI may 
prevent the brain from healing following an insult9. 
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Axon Degeneration 
 Axon degeneration has been shown to occur before, or directly cause, neuronal 
death in some research studies10. Therefore, scientists are interested in understanding the 
mechanisms behind axon degeneration10. In particular, Wallerian degeneration is 
considered a model of axon degeneration. Wallerian degeneration is defined as the 
degeneration of the distal end of an injured axon after a given period of time10. Scientists 
are not sure whether Wallerian degeneration is related to dying back neuropathies in 
which the distal nerves of an axon degenerates10. Figure 5 illustrates the models of 
Wallerian degeneration and dying back neuropathies. 
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Figure 5. The ‘dying back’ hypothesis and focal lesion  
hypothesis of axon degeneration10. 
The two hypotheses illustrate that nerves, following an insult, have much  
more axonal degeneration along the distal ends. The dying back hypothesis 
postulates that degeneration occurs at the distal end of an axon, and moves  
in a retrograde fashion. The focal lesion hypothesis postulates that focal  
lesions lead to Wallerian degeneration of distal axons, whereas proximal  
axons are unaffected. 
 
 
The slow Wallerian degeneration (WldS) gene mutation causes mice to have Wallerian 
degeneration that is delayed for two to three weeks following injury10. Scientists have 
observed that the WldS gene appears to reduce the number of axonal spheroids (small 
varicosities) in the gracile tract of mice with gracile axonal dystrophy (gad)10. 
Interestingly, axonal spheroids are also present in many neurodegenerative diseases10. So 
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axonal swelling disorders in the CNS, such as TBI, may reflect a Wallerian-related 
mechanism10. 
 
SLEEP CYCLE IN MAMMALS 
 Neurobiologists explain that mammals can be in a state of wakefulness or a state 
of sleep – either NREM sleep (non-rapid eye movement sleep) or REM (rapid eye 
movement sleep)11. Wakefulness is described as a range of behavioral states in which a 
mammal can move voluntarily and respond to internal and external stimuli11. While a 
mammal is sleeping, the mammal cycles through different stages of sleep. Figure 6 
depicts the different stages that a typical adult mammal may cycle through while asleep. 
 
 
 
  Figure 6. The sleep cycle11. 
  A representation of the sleep cycle of a young adult. The adult quickly 
  enters into deep NREM sleep (N3) and then cycles between NREM and REM sleep 
  about every ninety minutes. Over the night, NREM sleep becomes lighter and the 
  REM sleep stages becomes longer. 
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REM sleep is defined as a stage of sleep with rapid eye movement as well changes in 
heart rate and breathing11. On the other hand, during NREM sleep, a mammal only 
responds to the strongest and most vital stimuli11. Table 1 elaborates on the psychological 
features, physiological features, EEG pattern, and developmental changes associated with 
NREM sleep and REM sleep. 
 
 
 
Table 1. Features of wakefulness, NREM sleep, and REM sleep11. 
 
 
Sleep recordings with the electroencephalogram (EEG) and electromyogram (EMG) have 
helped scientists distinguish the characteristics of the sleep and wakefulness stages. 
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RELATIONSHIP BETWEEN SLEEP AND TBI 
 
Sleep Disorders after TBI 
 Sleep disturbances after TBI affect about 30%-70% of people12. A common sleep 
disturbance following TBI is insomnia – a condition in which a patient cannot fall and 
remain asleep12. Insomnia appears to be a delayed sleep-wake phase disorder or irregular 
sleep-wake rhythm disorder in some patients12. Thus, the TBI patients may be suffering 
from the disruption of their circadian rhythm13. Insomnia may be misdiagnosed in some 
TBI patients since it is usually associated with psychiatric conditions13. A patient who 
reports sleep-wake disturbances three months following a moderate to severe TBI may 
actually develop depression, anxiety, and apathy at about six and twelve months 
following the injury14.  
 It is quite difficult to find an effective treatment for post-traumatic insomnia. 
Benzodiazepines and non-benzodiazepine receptor agonists are used to treat sleep 
disorders, but these pharmacological agents have serious side effects12. Patients 
prescribed benzodiazepines are also more likely to abuse or become addicted to these 
drugs12. Scientists are working to find alternatives to these treatment options. 
 Stores and Stores explain that sleep disorders in children following TBI have not 
been studied extensively15. Annually, about 500,000 children from ages 0 to 14 report to 
the emergency room after sustaining TBI15. Due to the lack of research on sleep disorders 
in children following TBI, Stores and Stores encourage physicians to precisely diagnose 
sleep disorders in children so the appropriate treatment can be given15. Lastly, further 
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research is necessary to have a more solid understanding of the outcomes of childhood 
TBI. 
Modarres et al. mention that mice and human subjects have both similar and 
different symptoms after TBI16. Both mice and humans will have sleep disturbances, an 
inability to remain awake, and more slow waves while awake16. But, after TBI, mice have 
distinct theta wave: alpha wave ratios, and humans have distinct theta wave: beta wave 
ratios16. These findings may help clinicians and scientists understand the differences 
between the brains of injured and non-injured subjects16. 
 
Cellular Events Associated with Sleep Disruption 
 Sleep disturbance is common in patients who have suffered from mild TBI17. 
Mild TBI is defined as an injury that includes an LOC of less than 30 minutes and no 
skull fracture17. Sleep disruption appears to lead to epigenetic changes which cause 
metabolic disorders17. In rodent models, metabolites associated with hypoxia and 
oxidative stress are increased following a TBI17. More studies are necessary, however, to 
determine if these metabolites are present in human patients suffering TBI. 
 Bellesi et al. investigated whether periods of sleep and wakefulness affect the 
development of oligodendrocytes and oligodendrocyte precursor cells (OPCs)18. The 
study used mice models to observe gene expression in oligodendrocytes during periods of 
sleep, spontaneous wake, and acute sleep deprivation18. While asleep, genes involved in 
phospholipid synthesis and myelination or the promotion of OPC proliferation are highly 
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expressed18. On the other hand, genes involved in apoptosis, cellular stress, and OPC 
differentiation were highly expressed when mice were awake18. 
 Skopin et al. analyzed the sleep-wake behavior patterns in rats following the rat 
lateral fluid percussion (LFP) model of TBI19. These scientists were particularly 
interested in the neuropeptide orexin (ORX) also known as hypocretin. ORX, which is 
expressed in the lateral hypothalamus, regulates sleep-wake behavior19. In this study, 
there were less orexin-A (ORX-A) positive cells in the lateral hypothalamus of rats at 
about 1 month following TBI19. Therefore, this finding may explain the lack of arousal in 
the rats after the LFP injury19.  
Imbach et al. have suggested that TBI can disturb the regulation of the 
hypothalamic-pituitary-adrenal axis20. The scientists compared the levels of adrenal gland 
hormones in human subjects during the acute phase of TBI and six months after TBI20. 
There appeared to be a change in the diurnal cortisol pattern over time20. In regards to 
morning cortisol levels, the levels were lower in the acute phase of TBI than six months 
after TBI20. The decreased morning cortisol levels, during the acute phase of TBI, 
correlated with the development of post-traumatic excessive daytime sleepiness20. Other 
consequences of low cortisol levels are lack of alertness and difficulty awakening20. 
 
Benefit of Sleep after TBI 
 Since endocannabinoids appear to regulate alertness, Martinez-Vargas et al. 
measured the levels of cannabinoid receptor 1 (CB1R) protein and messenger RNA 
(mRNA) in the pons of rats during a 24 hour period21. These scientists were investigating 
 21 
whether the expression of the CB1R gene has diurnal variations. The levels of protein 
and mRNA were measured every four hours beginning at 9:00 am21. The experiment 
occurred under a 12:12 light/dark cycle; and the protein and mRNA levels were observed 
in two groups of rats: 1) rats sleep deprived for 24 hours and 2) rats sleep deprived for 24 
hours, but then allowed to sleep for two hours afterwards21. 
 The CB1R protein expression levels in the pons of the rats were highest during 
the light phase, and the CB1R mRNA levels in the pons of the rats were highest during 
the dark phase21. Furthermore, in the rat group that was only sleep deprived, there were 
no changes in the levels of CB1R protein or mRNA21. On the other hand, in the rat group 
that was sleep deprived but allowed to sleep two hours afterwards, there was an increase 
in CB1R protein levels and a decrease in CB1R mRNA levels21. Figure 7 illustrates the 
effect of sleep deprivation and sleep rebound on the levels of CB1R. 
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Figure 7. Effect of sleep deprivation and sleep rebound on CB1R expression21. 
(A) Western immunoblotting of the CB1R receptor in the rat pons. C represents 
control group, D represents 24 hours sleep deprivation, and R represents 24  
hours of sleep followed by 2 hours of sleep. (B) Mean +/- S.E.M. (Standard Error of the 
Mean) of densitometry for the 53-kDa band. Sleep deprivation has no impact on CB1R 
expression, but sleep rebound significantly increases its expression; *P<0.05. 
 
 
Martinez-Vargas et al. suggest that the CB1R expression appears to be influenced by 
sleep, and that endocannabinoids may have a role in brain functions during sleep21.   
Shohami et al. explain that endocannabinoids may have neuroprotective effects 
following ischemic brain injuries and TBI22. Endocannabinoids appear to inhibit the 
release and accumulation of glutamate, reactive oxygen species (ROS), and cytokines 
following TBI22. Glutamate, ROS, and cytokines are harmful mediators in the brain that 
lead to vasoconstriction, neuroinflammation, neuronal cell death, and, ultimately, 
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secondary damage22. Thus, the endocannabinoids may prevent the secondary damage 
after TBI from occurring22. Endocannabinoids also appear to promote stem cell 
differentiation and migration, which can inhibit secondary damage22.   
          
Neuroprotective Role of Sleep Deprivation 
 Martinez-Vargas et al. have determined that sleep deprivation following a TBI 
may offer neuroprotection to rats23. Rats that underwent total sleep deprivation (TSD) for 
24 hours following TBI had less morphological damage in the brain than rats that 
underwent rapid eye-movement sleep deprivation (REMSD) for 24 hours following 
TBI23. Furthermore, the rats that underwent TSD performed better in neurobiological 
tests than the rats that underwent REMSD23. The scientists suggest that TSD leads to 
slow wave brain activity (present during NREM sleep) which may have a neuroprotective 
role following TBI23. NREM sleep also appears to restore health in the brain23. 
 Weil et al. investigated whether sleep deprivation would increase 
neuroinflammation and neurodegeneration in mice after global ischemia24. The study 
determined that acute sleep deprivation reduced inflammation in the peripheral nervous 
system and central nervous system24. In particular, acute sleep deprivation increased 
expression of the anti-inflammatory cytokines IL-6 and IL-1024. Acute sleep deprivation 
also reduced the expression of IL-1β and reduced neuronal damage in the hippocampus24. 
The scientists suggest that IL-1β is associated with a decrease in neuronal damage24. 
 Moldovan et al. have studied the effect of sleep deprivation on outcomes after a 
stroke25. Twenty young male mice were used as subjects in the study25. Each mouse mice 
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suffered focal cerebral ischemia by undergoing reversible right middle cerebral artery 
occlusion (MCAO) for 90 minutes25. But, ten rats in the experimental group had the 
MCAO procedure done after having TSD for 6 hours, and ten other rats were in a control 
group25.  
One week following the stroke, several behavioral tests were conducted to assess 
the neurological functioning of the rats25. Two particular behavior test conducted to 
assess bilateral sensorimotor coordination were the rotor-rod test and the inclined plane 
task25. During the rotor-rod test, the rats attempted to maintain both balance and motion 
on an elevated horizontal rod set at three different rotational speeds: 0 rotations/minute, 3 
rotations/minute, and 6 rotations/minute25. The inclined plane task measured if a mouse 
could maintain its position at a particular angle on an inclined plane25. Figure 8 presents 
the results of the rotor-rod test. 
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Figure 8. The Rotor-Rod test25. 
The rotor-rod traversing time (left side) and rotor-rod performance score (right side) 
for the three different rotational velocities. Error bars indicate S.E.M, and asterisks 
indicate statistical differences. 
 
 
In regards to the rotor-rod test, after the MCAO procedure, the beam traversing 
performance was affected in the control group, but not affected in the TSD group25. In 
considering all of the rotational speeds, the traversing time was increased by about 2 
seconds and the performance score was reduced by 1 point for the control rats25. 
Figure 9 displays the results of the inclined plane task. 
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 Figure 9. The inclined plane task25. 
 The mean daily measures of the relative angle at which the rats could maintain their  
 position (left side) and the grouped averages of the relative angle at which the rats could   
 maintain their position. The vertical dashed line on the left side represents the  
 conventional limit for the rapid early recovery during the first 3 days after MCAO. Error  
 bars indicate S.E.M. Statistical differences are represented with an asterisk. 
 
 
 During the inclined plane task, the rats could maintain their position up to an 
angle of 35 degrees25. At the baseline period and at days 4-7 following MCAO, there was 
no difference in the relative angle for the inclined plane task between the control group 
and the TSD group25. But, on days 1-3 following MCAO, the control group had a smaller 
relative angle for the inclined plane task than the TSD group25. 
 Moldovan et al. also measured the infarct volume and indicators of neuronal 
injury in the rats after MCAO. Figure 10 presents the findings regarding the findings. 
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 Figure 10. Histology suggesting delayed neuronal death at 7 days post MCAO25. 
 Low-power images of NeuN staining in the control group (A) and TSD group (B) that  
 estimate the infarct volumes in panel (C). Images of fluoro-Jade B (FJB) staining are  
 illustrated in the control group (D) and the TSD group (E). Infarct core (IC) is outlined  
 with a red dotted line. PI refers to peri-infarct. The corresponding number of FJB cells,  
 which represent degenerating neurons, are shown in panel (F). Immunohistochemical  
 staining of cleaved caspase 3 (CC3), which are apoptotic cells, is shown in the control  
 group (G) and the TSD group (H). The corresponding number of CC3 cells is presented  
 in panel (I). Error bars include S.E.M. Statistical differences are represented by an  
 asterisk. 
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Based on the histology, at 7 days post-MCAO, TSD rats had less morphological damage 
in the brain than the control rats25. The control rats had a larger infarct volume than the 
TSD rats, which Moldovan et al. suggest may reflect the worse behavioral test 
performance25. The control rats also had a greater amount of FJB stained cells, which are 
degenerating neurons, in the infarct core than the TSD rats25. Lastly, the control group 
had a greater amount of CC3 stained cells, which are apoptic cells, than the TSD group25. 
 
 
Detrimental Effect of Sleep Deprivation 
 
 Gao et al. investigated whether sleep disruption worsened brain damage in rats 
after focal cerebral ischemia26. The study included fifty rats that were about 8 weeks 
old26. The rats suffered cerebral ischemia after undergoing an occlusion of the middle 
cerebral artery26. The rats were placed in one of two groups:1) sleep disruption including 
sleep deprivation for 12 hours (SDpv12h) and 2) sleep disturbances (SDis) by SDpv12h 
for three consecutive days26. Gao et al. determined that both sleep deprivation and sleep 
disruption over the course of three days worsened brain damage26. The exact mechanisms 
by which sleep deprivation and sleep disruption exacerbate cerebral ischemia has not 
been determined in this study. More studies should be conducted in the future to identify 
these mechanisms. 
 
 
PROGESTERONE TREATMENT 
 Progesterone has been shown to provide neuroprotective effects following the 
CNS injuries of cerebral ischemia and TBI. But, Gibson et al. explain that there are no 
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sufficient data regarding whether progesterone can reduce lesion volume following the 
aforementioned CNS injuries27. Gibson et al. also explain that the methodology of many 
progesterone treatment studies, involving rodent models, has been poor27. As a result, 
scientists may need to conduct more studies in order to learn more about the limitations 
of progesterone treatment27. With this insight, health care providers can determine if 
progesterone has the potential of efficacy in a clinical setting27. 
 
Inflammation 
 Clevenger et al. studied the role of endogenous female sex steroids in reducing the 
volume of cortical injury and reducing the neuroinflammatory response28. The subjects of 
the experiment were seventy-six adult (8-12 week old) male and female mice28. The three 
groups of mice [male CCI, female CCI, and ovariectomy CCI (ovex)] underwent 
anesthesia, craniotomy, and a CCI model of TBI28. The depth of impact from the CCI 
device varied from 0 mm (sham) to 2 mm severe28. A test called the cylinder test—a test 
used to analyze functional limb use bias – was performed to understand the functional 
behavior of the mice following the procedure28. In addition, immunohistochemistry was 
performed to analyze astrogliosis and microgliosis following the CCI procedure28. 
 The behavioral testing showed that, due to the injury occurring in the right side of 
the cortex, all the injured groups had a significant decrease in the use of the left paw 
following the injury28. The injured group with the greatest reduction in left paw usage 
was the male CCI group, and the injured group with the least reduction in left paw usage 
was the female CCI group28. Lastly, the ovex CCI group had significantly reduced left 
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paw usage when compared to the sham group and the female CCI group28. Therefore, 
there appears to be a greater motor deficit in the male mice and the ovex mice28. 
 Immunolabeling for Iba-1, a macrophage/microglia specific calcium binding 
protein, was used to assess the levels of microgliosis28. Figure 11 displays the 
immunolabeling for Iba-1 in the peri-injury cortex and the reticular thalamic nucleus 
(RTN) for each animal group. The sham groups had low levels of the Iba-1 staining28. 
Male mice had a higher level of Iba-1 staining than the female mice, although the level of 
the staining was not statistically significant between the two groups28. The ovex mice, in 
comparison to female mice, had significantly higher levels of Iba-1 staining28. 
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Figure 11. Iba-1 immunohistochemistry to assess microgliosis28. 
The Iba-1 immunohistochemistry staining in the peri-injury cortex (CTX) is  
represented by panels A through D. Sham CTX is represented by panel A.  
Male CTX is represented by panel B. Female CTX is represented by panel C. 
Ovariectomized female (ovex) CTX is represented by panel D. Panel E  
represents the total levels of Iba-1 staining in the peri-injury cortex. 
Injury > sham, p < 0.0001. Ovex CCI > female CCI, *p=0.01. 
The Iba-1 immunohistochemistry staining in the reticular thalamic nucleus 
(RTN) is represented by panels F through I. Sham RTN is represented by panel F. 
Male RTN is represented by panel G. Female RTN is represented by panel H. 
Ovex RTN is measured by panel I. Panel J represents the total levels of Iba-1 
staining in the RTN. Injury > sham, p < 0.0001. Ovex CCI > female CCI, 
*p = 0.0002. 
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Immunolabeling for Glial fibrillary acid protein (GFAP) was performed to assess 
the levels of astrogliosis28. Figure 12 presents GFAP immunofluorescence in the peri-
injury cortex and RTN of each animal group28. 
 
 
 
Figure 12. GFAP immunohistochemistry to assess astrogliosis28. 
Glial fibrillary acidic protein (GFAP) immunohistochemistry staining in the 
peri-injury cortex (CTX) is represented by panels A through D. Sham CTX is  
represented by panel A. Male CTX is represented by panel B. Female CTX is 
represented by panel C. Ovariectomized female (ovex) CTX is represented by  
panel D. Panel E represents the total levels of GFAP staining in the peri-injury  
cortex. Injury > sham, p = 0.04. Ovex CCI > male CCI, *p=0.01. Ovex CCI > 
female CCI, **p = 0.002. The GFAP immunohistochemistry staining in the 
 reticular thalamic nucleus (RTN) is represented by panels F through I.  
Sham RTN is represented by panel F. Male RTN is represented by panel G.  
Female RTN is represented by panel H. Ovex RTN is measured by panel I.  
Panel J represents the total levels of GFAP staining in the RTN. Injury > sham, p < 
0.0001.  
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The injured animals had higher levels of GFAP staining than the sham animals in the 
peri-injury cortex and the RTN28. In the peri-injury cortex, ovex female mice had higher 
levels of GFAP than male and female mice28. On the other hand, regarding the RTN, 
there were only group differences between the injury groups and the sham groups28. 
 Clevenger et al. have determined that female mice suffer less neuroinflammation 
and less motor dysfunction following experimental TBI28. In particular, when 
endogenous female sex steroids were removed in ovex mice, these mice suffered worse 
histological and behavioral outcomes than the female mice without an ovariectomy28. 
Thus, the study supports the assertion that progesterone may provide neuroprotective 
effects following a TBI28. Future experimental studies, however, will be necessary to 
further understand how progesterone reduces neuroinflammation (astrogliosis and 
microgliosis) in the brain following TBI. 
 Jones et al. suggest that progesterone may confer neuroprotective effects 
independent of the inflammatory response and growth factor expression29. Jones et al. 
utilized the aseptic cerebral injury (ACI) procedure – which produces similar 
pathophysiological effects as the CCI model and the fluid percussion injury model – to 
understand the histological and functional outcomes following TBI in mice29. The ACI 
procedure consisted of applying a small amount of liquid nitrogen on the exposed skull of 
the mice (over the right parietal cortex) for fifteen seconds29. The subjects for the 
experiment were sixty-seven male mice (31 progesterone-treated, 31 vehicle, and 5 
untreated) and four virgin mice between 8 and 12 weeks of age29. 
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 The ACI procedure led to the development of necrotic tissue in the right parietal 
cortex of the male and female mice29. Forty-eight hours after the injury, female mice had 
a significantly smaller lesion volume than male mice of the same age29. Furthermore, 
male mice treated with progesterone had a significantly reduced lesion volume than 
vehicle treated mice forty-eight hours after injury29. The ACI procedure also led to the 
expression of pro-inflammatory cytokines and growth factors. Figure 13 displays the 
levels of Brain-derived neurotrophic factor (BDNF), TNF-α, Interleukin-1β (IL-1β), and 
Granulocyte-colony stimulating factor (G-CSF) in the vehicle and progesterone-treated 
mice after the ACI procedure. 
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Figure 13. The effect of ACI and progesterone treatment in ipsilateral hemispheres 
on TNF-α, IL-1β, BDNF, and G-CSF gene expression29. 
The gene expression levels were measured at 6 hours (n =3 for TNF-α and BDNF; 
n = 6 for IL-1β and G-CSF), 24 hours (n = 3 for all groups), and 48 hours (n = 3 for 
all groups), as quantified by RT-PCR (TaqMan) using cyclophilin E as a loading control. 
*P < 0.05 using a one-way ANOVA at specific time points compared to sham. 
G-CSF mRNA was not detected at 48 hours (N.D.). 
 
 
 The injured mice had higher levels of expression of IL-1β mRNA and TNF-α  
mRNA in the ipsilateral hemisphere than the sham mice29. Following the progesterone 
treatment, there was reduction in expression of IL-1β in the progesterone-treated mice at 
24 hours and 48 hours after injury29. But, overall, the reduction in expression of IL-1β 
was not significantly different between the progesterone-treated mice and the vehicle-
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treated mice29. The progesterone treatment had no effect on TNF-α expression. Lastly, 
the progesterone treatment did not affect expression of BDNF mRNA and G-CSF 
mRNA29. 
 The experiment conducted by Jones et al. demonstrated that progesterone 
treatment can reduce cell loss and improve cognitive function in male mice following 
TBI29. But, the experiment did not determine if progesterone has any effect on the 
expression of pro-inflammatory genes or growth factors29. Jones et al. mention that 
scientists are unsure whether the inflammatory response leads to protective or detrimental 
effects following TBI29.  In addition, the role of progesterone treatment in the 
inflammatory response is not well characterized. So more experimental studies will be 
necessary to have a better understanding of the impact of progesterone treatment. 
 
 
Cerebral Edema 
 
 Cerebral edema –swelling in the brain due to excess fluid – is a side effect of 
TBI30. The side effects of cerebral edema include intracranial swelling, free radical 
production, and neuronal death30. Studies have shown that progesterone can reduce 
cerebral edema in mice suffering from TBI. Roof et al., have conducted two experiments 
to determine at which time period, after TBI, is the administration of progesterone most 
effective30. 
 In the first experiment, Roof et al., assessed the reduction of cerebral edema in 
male and female rats after injecting the rats with progesterone about 1 hour following 
TBI. Fifty-two male and fifty-two female rats, at about 90 days of age, were selected for 
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the experiment30. Each rat was treated with anesthesia prior to undergoing a CCI model 
of TBI (in order to damage the medial frontal cortex)30. Rats with significant bleeding 
after the surgery were excluded from the experiment. About fifty-six rats were placed in 
the treatment group and forty-eight rats were placed in the control group30. The rats were 
treated with progesterone (4 mg/ml), dissolved in peanut oil, one hour following injury30. 
The first injection (4 mg/kg) was delivered intraperitoneally30. The following injections 
(4 mg/kg) – delivered 6 hours post-injury, 24 hours post-injury, and once every 24 hours 
before sacrificing the rats – were delivered subcutaneously30. Control rats received the 
same injections of oil vehicles within the same time frames30. 
The study found that progesterone treated rats had less edema than those mice 
receiving the vehicle alone30. Figure 14 displays the edema present in male and female 
rats treated with either the oil vehicle or progesterone following brain injury. 
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 Figure 14. Edema formation in male and female rats30. 
 The edema present in male (A) and female (B) rats treated with either oil vehicle or   
 progesterone following injury of the medial frontal cortex. The asterisk indicates a  
 significant difference between the experimental group and the control group 
 at a point in time. 
 
 
The findings demonstrate that there was a significant difference in edema formation in 
male and female rats at six hours post-injury, one day post-injury, and three days post-
injury30. Another finding of major importance is that three days following injury, the 
edema observed in progesterone-treated male and female mice was at the same level as 
that of non-treated mice at seven days post-injury30. 
 In a second experiment, Roof et al. planned to determine the effect of delayed 
progesterone injections on edema formation30. The subjects included forty-eight male and 
forty-eight female rats at ninety days of age30. The surgery and treatment conditions were 
the same as the first experiment, but, in this experiment, the rats received treatment at 
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different times. In this experiment, one-fourth of the rats were given injections at one 
hour post-injury, one-fourth at six hours post-injury, one -fourth at twenty-four hours post 
injury, and one-fourth at forty-eight hours post-injury30. At three days post-injury, the rats 
were sacrificed and decapitated in order to assess edema formation. 
 The amount of edema reduction appeared to be associated with when the timing 
of the progesterone treatment30. Figure 15 illustrates the association between edema 
reduction and initiation of progesterone treatment. 
 
 
 
Figure 15. Edema formation in male and female rats with treatment delay30. 
The edema present in male (A) and female (B) rats after cortical injury. Rats were treated 
with either oil vehicle or progesterone at either 1 hour post-injury, 6 hours post-injury, 24 
hours post-injury, or 48 hours post-injury. The asterisk indicates a significant 
difference between the experimental group and the control group at a point in time. 
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For the male and female rats, progesterone treatment reduced cerebral edema when given  
one hour after injury, six hours after injury, and twenty-four hours after injury30. But, 
progesterone treatments initiated forty-eight hours after injury were not effective in 
reducing edema30. Roof et al., suggest that progesterone may be therapeutic even in cases 
where it may not be feasible to quickly start treatment right after a brain injury. 
 Wright et al. have investigated whether serum progesterone levels correlate with 
decreased cerebral edema in male mice after TBI. The scientists suggest that 
understanding this relationship will be necessary in generating a dose-response curve for 
the clinical use of progesterone31. Eighteen male rats at 90 days of age (300-400 g) were 
used as subjects31. The rats were anesthetized, and then underwent a craniotomy and CCI 
model of TBI31. Following the injury, rats were placed in one of three groups: 1) injured 
rat treated with progesterone (4 mg/kg), 2) injury rat treated with vehicle (oil), and 3) 
uninjured controls given vehicle (sham)31. Progesterone, used in this experiment, was 
created from progesterone powder mixed with peanut oil (vehicle) at a concentration of 4 
mg/mL and stored at 30°C31. Lastly, the progesterone and vehicle was injected into 
intraperitoneally at one hour post-injury, 6 hours post-injury, and 24 hours post-injury. 
 Serum progesterone levels were measured after the first injection, which occurred 
one hour after injury31. The serum progesterone levels were measured at time points of 2 
hours, 6 hours, 24 hours, and 48 hours following the initial injection. Figure 16 displays 
the serum progesterone levels in the treatment group, control group, and sham group. 
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Figure 16. Serum progesterone levels31. 
The serum progesterone levels in the treatment group, control group, and vehicle group 
measured at 2 hours, 6 hours, 24 hours, and 48 hours after the initial injection. The 
highest levels of progesterone observed occurred between 0 and 6 hours. 
 
 
Serum progesterone levels were highest in the treatment group at time points of 2 hours, 
6 hours, 24 hours, and 48 hours after the first injection. Wright et al. further explain that 
the brains of injured animals given the vehicle had greater water content than the 
uninjured group and the injured progesterone-treated rats31. Thus, it appears that there is a 
significant relationship between serum progesterone levels and the degree of cerebral 
edema following TBI31. Figure 17 provides information about the edema levels in the 
different groups of rats31. 
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Figure 17. Edema levels 48 hours post-injury31. 
The progesterone and vehicle treated animals with injury had edema  
when compared to sham-operated controls. The progesterone treatment  
group was statistically different from vehicle-treated injured rats and  
shams at p < 0.05. The brains of the injured animals treated with vehicle 
had higher levels of edema than the other two treatment groups (p < 0.05). 
 
 
Wright et al. further explain that, at forty-eight hours post-injury, edema was reduced by 
37% in the progesterone-treated group compared to controls31. The study also determined 
that the higher the serum progesterone level, the lower the percent edema31. Wright et al. 
suggest that progesterone may also reduce the excitotoxicity associated with TBI by 
reducing the effects of glutamate and increasing the effects of GABA31. 
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CONCLUSION 
 TBI is a serious public health concern. Although numerous animal model studies 
have been carried out to assess TBI and possible treatments for this injury, there has not 
been any conclusive evidence about how this condition can be treated effectively. Sleep 
has been shown to make rodents more alert and has been associated with the removal of 
neurotoxic waste as well as metabolic homeostasis following TBI. On the other hand, 
sleep deprivation appears to have a neuroprotective role in rodents following TBI. Sleep 
deprivation promotes restorative slow wave brain activity and reduces inflammation in 
the central nervous system. 
 In regards to progesterone treatment, rodents given this sex steroid after TBI 
appeared to have improved outcomes after the injury. For instance, scientists observed 
reduced neuroinflammation in the brains of rodents after this treatment. Scientists also 
determined that progesterone may have a role in reducing cerebral edema in rodents after 
brain injury. But, scientists and clinicians are not sure what dose of progesterone would 
be effective, if it can be effective at all, in human subjects suffering from TBI. 
 Scientists have made great strides in terms of TBI research. But, unfortunately, 
further research studies must be conducted to have a better understanding of therapeutic 
approaches for TBI. These studies should include both experimental studies with animal 
subjects as well as clinical studies with human subjects. With further research, clinicians 
can determine which particular therapy will be most effective in treating a patient.  
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